Bulletin de Périodique
Drug Testing and Analysis , Vol.11, n°6 - June 2019
Paru le :
01/06/2019
Année
2019
Page(s) :
739-918
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
SELECTION :
- Identification of new urinary gamma-hydroxybutyric acid markers applying untargeted metabolomics analysis following placebo-controlled administration to humans. Steuer A.E., Raeber J., Steuer C., Boxler M.I., Dornbierer D.A., Bosch O.G., et al., p. 813-823.
- Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous detection of 10 illicit drugs in oral fluid collected with FLOQSwabs™ and application to real samples. Fabresse N., Aouad H., Knapp A., Mayer C., Etting I., Larabi I.A., et al., p. 824-832.
- Ion mobility spectrometry as a fast screening tool for synthetic cannabinoids to uncover drug trafficking in jail via herbal mixtures, paper, food, and cosmetics. Metternich S., Zörntlein S., Schönberger T., Huhn C., p. 833-846.
- Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry. Yeter O., Ozturk Y.E., p. 847-858.
- Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation. Luginbühl M., Weinmann W., Butzke I., Pfeifer P., p. 859-869.
- Identification of new urinary gamma-hydroxybutyric acid markers applying untargeted metabolomics analysis following placebo-controlled administration to humans. Steuer A.E., Raeber J., Steuer C., Boxler M.I., Dornbierer D.A., Bosch O.G., et al., p. 813-823.
- Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous detection of 10 illicit drugs in oral fluid collected with FLOQSwabs™ and application to real samples. Fabresse N., Aouad H., Knapp A., Mayer C., Etting I., Larabi I.A., et al., p. 824-832.
- Ion mobility spectrometry as a fast screening tool for synthetic cannabinoids to uncover drug trafficking in jail via herbal mixtures, paper, food, and cosmetics. Metternich S., Zörntlein S., Schönberger T., Huhn C., p. 833-846.
- Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry. Yeter O., Ozturk Y.E., p. 847-858.
- Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation. Luginbühl M., Weinmann W., Butzke I., Pfeifer P., p. 859-869.
Cote :
Abonnement
Historique